Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,350
-2,700 (-7.29%)
At close: Jul 28, 2026

Next Biomedical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
284,325733,427331,554---
Market Cap Growth
-38.94%121.21%----
Enterprise Value
258,147714,251316,300---
Last Close Price
34350.0089400.0041000.00---
PE Ratio
--115.95---
PS Ratio
16.9044.5134.74---
PB Ratio
5.8115.257.34---
P/TBV Ratio
5.8415.357.39---
P/OCF Ratio
793.76586.68----
EV/Sales Ratio
15.3443.3533.15---
Debt / Equity Ratio
0.150.160.240.700.566.25
Net Debt / Equity Ratio
-0.53-0.61-0.68-0.17-0.191.92
Net Debt / EBITDA Ratio
36.79145.679.950.580.71-1.49
Net Debt / FCF Ratio
9.6515.4018.700.660.45-1.60
Asset Turnover
0.280.280.220.160.080.07
Inventory Turnover
1.851.791.601.371.611.83
Quick Ratio
4.594.893.681.351.381.70
Current Ratio
5.115.383.951.571.591.82
Return on Equity (ROE)
-0.08%-0.67%9.28%-41.64%-46.30%-
Return on Assets (ROA)
-1.31%-0.76%-5.05%-10.57%-10.03%-13.55%
Return on Capital Employed (ROCE)
-2.40%-1.40%-7.60%-28.70%-27.30%-26.10%
Earnings Yield
-0.01%-0.04%0.86%---
FCF Yield
-0.95%-0.26%-0.50%---
Buyback Yield / Dilution
-6.75%-12.84%-14.72%-1.10%-28.34%-13.05%